TI
MIRM icon

Tidal Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Tidal Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Sell
2,216
-3,227
-59% -$324K ﹤0.01% 2368
2026
Q1 		$503K Buy
5,443
+1,685
+45% +$159K ﹤0.01% 1829
2025
Q4 		$297K Buy
3,758
+921
+32% +$66.1K ﹤0.01% 1863
2025
Q3 		$208K Buy
+2,837
New +$180K ﹤0.01% 1925
2025
Q2 		– Sell
-5,260
Closed -$237K – 2006
2025
Q1 		$237K Buy
+5,260
New +$248K ﹤0.01% 1628

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tidal Investments's MIRM Position: Q2 2026 in Review

Tidal Investments reduced its Mirum Pharmaceuticals (MIRM) stake by 59% in Q2 2026, selling an estimated $324K and leaving 2,216 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Tidal Investments first reported a position in MIRM in Q1 2025 and has held it in 5 quarters since. The position peaked at $503K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Tidal Investments held 2,216 shares of Mirum Pharmaceuticals worth $259K as of Q2 2026.
  • Tidal Investments sold 3,227 Mirum Pharmaceuticals shares in Q2 2026, an estimated $324K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #2368 holding.
  • Tidal Investments first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Tidal Investments's Mirum Pharmaceuticals position peaked at $503K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.